Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
Phase 1 Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 701 in Subjects With Multiple Myeloma
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.